Take a virtual tour of Femtonics' chemistry department, where our research chemists design and develop new caged neurotransmitters for neuroscience research, with a focus on DNI-GLU-TFA.

This dinitro-indoline-masked form of glutamate releases the bioactive glutamate more rapidly than any other commercially available compound. It was developed for high-quantum yield requiring less irradiation for release, so its effective concentration is lower than other caging scaffolds. The caged compound exists as trifluoroacetic acid salted form (DNI-Glu*TFA) ensuring good solubility, stability and low hygroscopicity.

DNI-Glu is a compound developed in-house, only available from Femtonics. See more at [ Ссылка ].

(Video by Attila Csomós.)

свернуть